Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16411 | Camidanlumab tesirine | 1 | Terminated | 1 |
| DB09037 | Pembrolizumab | 1 | Terminated | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16411 | Camidanlumab tesirine | 1 | Terminated | 1 |
| DB09037 | Pembrolizumab | 1 | Terminated | 1 |